Call for Service Provision on "Advancing Personalised Oncology"


The canSERV Consortium announces its first Challenge-Call on "Advancing Personalised Oncology".Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall budget of EUR 500,000. The aim of this call is to accelerate knowledge gain in personalised oncology with specific emphasis on multi-level data-based

Consortium & Contractor Meeting, 29-30.03.2023, Vienna


This year's meeting of the Instand NGS4P project consortium and contractors was held in Vienna, Austria, as a hybrid meeting combining both face-to-face and online formats. The two-day event provided a valuable platform for contractors to present their innovative prototypes to consortium members present from across Europe.In addition, the clinical project partners also had the

OECI dedicates a Special Edition Newsletter to Instand-NGS4P


Instand-NGS4P Beneficiary, OECI - the Organisation of European Cancer Institutes - has dedicated an entire Newsletter to the Instand-NGS4P project. The Newsletter describes the aims of the project, and progress made to date. This is an important dissemination tool, with the OECI Audience comprising 1300 contacts including: OECI Membership; Cancer Organisations and & relevant cancer

Event announcement: EASI-Genomics Workshop on Implementing Genomic Research Projects


This workshop addresses the key issues facing genomic research such as ethical and legal issues, privacy and data protection, data standardisation and implementation of standardised sample workflows. For further information on this event organised jointly by BBMRI-ERIC and EASI-Genomics, please visit Workshop on Implementing Genomic Research Projects | EASI-Genomics

New CEN Technical Specifications on NGS Workflow enter final technical commenting period


Analysis carried out by Instand-NGS4P´s WP7 of existing gaps in current standardization led to the proposal of 2 new Work Items for development in partnership with CEN/TC 140 “In vitro diagnostic medical devices” WG3 “Quality Management in the Medical Laboratory”:00140151 - prCEN/TS XXX In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 1: Human

Consortium Meeting, 22-23.06.2022, Florence


The Consortium Meeting of the EU-Instand NGS4P project took place in Florence, Italy on June 22-23, 2022, and was hosted by the University of Florence (Università degli Studi di Firenze | UniFI). It was the first face-to-face meeting since the 2020 Kick-off meeting in Graz due to corona pandemic restrictions.The 2 day-meeting was opened by Kurt

Contract Award for PCP Phase 1 – Solution Design


We are excited to announce that the Contract Award Notice ‘Results of the procurement procedure’ of the Instand-NGS4P Request for Tender has today been published in the Official Journal of the European Union supplement (OJ/S) and is available on the TED database under 2022/S 095-263180. The tenderers who have successfully concluded Framework Agreements and Specific

H2020 European Genomics Infrastructure project EASI-Genomics announces Fourth Call for Proposals for Transnational Access Projects


H2020 EASI-Genomics (European Advanced infraStructure for Innovative Genomics) announces the Fourth Call for Proposals for Transnational Access Projects, supporting integrative projects including high-throughput and cutting-edge sequencing and complex bioinformatics analysis.Timeline:Call open: 01.03.2022 8:00 CETProposal submission deadline: 10.04.2022 23:55 CETNotification of applicants: by 01.07.2022Start of projects: latest 4 months after notification EASI-Genomics´ novel infrastructure is accessible worldwide

Q&As on the Tendering Process now available


The answers to your questions regarding all aspects of the Tendering Process are now available on the Request for Tender page!Questions and answers will be updated regularly until the 10th of December. If you can´t find the answer to your specific question, please write to instand-tender@medunigraz.at, and you will receive a reply within a few

1 2 3